nafamostat mesylate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
1 FDA-registered drug labeler
AURORE PHARMACEUTICALS PRIVATE LIMITED
Why It Matters
Sectors
Health
Downstream UsesNo data available
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Vendor Pricing
$92.00/gBLD Pharmatech GmbH
CountryGermany
Pack$460.00 / 5 g
Purity98%
Vendors16 available
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
15 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| Ambeed, Inc. | United States | $92.00 | 5 g | 98% |
| AK Scientific Specialized | United States | $92.00 | 5 g | 95% |
| Combi-Blocks, Inc. | United States | $92.00 | 5 g | 98% |
| AK Scientific, Inc. | United States | $119.00 | 5 g | 98% |
| BLD Pharmatech Co., Limited | United States | $135.00 | 1 g | 98% |
| BLD Pharmatech Ltd. | China | $135.00 | 1 g | 98% |
| MedKoo Biosciences, Inc | United States | $232.50 | 20 g | 98% |
| AstaTech, Inc | United States | $308.00 | 250 mg | 98% |
| TargetMol Chemicals | China → United States | $620.00 | 500 mg | 99.76% |
| MedChemExpress MCE | Sweden | $951.06 | 500 mg | 99.97% |
| Cayman Europe | Estonia | $9448.60 | 50 mg | 98% |
| Sigma-Aldrich (Rush Stock) | Germany | $20778.20 | 50 mg | 98% |
| Sigma-Aldrich | Germany | $20778.20 | 50 mg | 98% |
| Key Organics Ltd. | United Kingdom | $26900.00 | 10 mg | 97% |
| TimTec, LLC | United States | $32000.00 | 10 mg | 90% |
Chemical Identity
CAS82956-11-4
PubChem CID5311180
DTXSIDDTXSID7046128
FormulaC21H25N5O8S2
Mol. Weight539.6 g/mol
SMILESCS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N
Data Sources
53111802026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/nafamostat mesylate/cids/JSON
Archive: data/sources/pubchem_name/nafamostat mesylate.json
CAS 82956-11-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json